Discover 874 paid clinical trials in Indianapolis, Indiana. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Clinical trials in Indianapolis focus on numerous chronic conditions such as lupus, heart disease, and dystrophy. The city’s leading healthcare institutions are actively recruiting participants seeking paid clinical research opportunities as a healthy volunteer, as well as those looking for studies related to a particular health condition to help advance medical knowledge and treatment options in these critical areas.
Filter
2
Filter results
Results: 874
A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
Location: Indianapolis IN, Clarksville IN, Columbus OH,
Sponsor: Apollo Therapeutics Ltd
Sex: All
Age: 18 - 65
Code: NCT07599813
Phase2, Recruiting
Phase 2/3 Clinical Study of QRX003 Lotion in Subjects With Netherton Syndrome
for
Netherton Syndrome
Location: Indianapolis IN, Quincy MA, San Antonio TX, Fremont CA
Sponsor: Quoin Pharmaceuticals
Sex: All
Age: 4+
Code: NCT07538583
Phase2, Phase3, Recruiting
A Study of LY4005130 in Adult Participants With Non-Segmental Vitiligo
for
Vitiligo, Non-Segmental Vitiligo (NSV)
Location: Indianapolis IN, Troy MI, London, Sandy Springs GA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70+
Code: NCT07533019
Phase2, Recruiting
Study of the Efficacy and Safety of ICP-332 in Participants With Prurigo Nodularis
for
Prurigo Nodularis (PN)
Location: Indianapolis IN, Caledonia MI, Troy MI,
Sponsor: Beijing InnoCare Pharma Tech Co., Ltd.
Sex: All
Age: 18 - 70+
Code: NCT07236099
Phase2, Recruiting
A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.
for
Severe Alopecia Areata
Location: Indianapolis IN, Papillion NE, Omaha NE, San Antonio TX,
Sponsor: Pfizer
Sex: All
Age: 6 - 14
Code: NCT07029828
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
for
Plaque Psoriasis
Location: Indianapolis IN, Mason OH, New Albany IN, Louisville KY,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 40+
Code: NCT07116967
Phase3, Recruiting
A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
for
Plaque Psoriasis
Location: Indianapolis IN, Canton OH, Lorain OH, Detroit MI,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 12 - 17
Code: NCT06979453
Phase3, Recruiting
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
for
Alopecia Areata
Location: Indianapolis IN, Mason OH, Clarksville IN,
Sponsor: Sun Pharmaceutical Industries, Inc.
Sex: All
Age: 12 - 17
Code: NCT07133308
Phase3, Recruiting
A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)